Sono-Tek Corporation develops and manufactures ultrasonic coating systems and has been shifting its product mix toward larger, higher-value production machines that carry higher average selling prices. That shift has supported profitability even with relatively modest revenue growth. The latest quarter offers insight into whether the company can maintain margin progress as clean energy demand eases and whether strength in medical and electronics markets can offset that softness. A rising backlog and solid balance sheet make it worth watching how management turns orders into revenue ahead of the next fiscal year.
For the fiscal second quarter ended August 31, 2026, total revenue reached approximately $5.23 million compared with $5.16 million in the same quarter a year earlier. First-half fiscal 2027 revenue increased 6% to roughly $10.9 million from $10.3 million in the prior-year period.
Gross profit for the second quarter came in at about $2.8 million, up 7% year over year, with a gross margin near 53%. Management pointed to a favorable product and geographic mix. Over the first half, gross profit rose 14% to approximately $6 million, pushing the gross margin to 55% from 51%.
Operating income for the quarter fell 9%, or $39,000, to $382,000 because of higher operating expenses. Net income declined to roughly $366,000 from $424,000, resulting in EPS of $0.02 versus $0.03. For the six-month period, net income rose to about $1.11 million from $909,000, with EPS of $0.07 compared with $0.06.
Investor reaction to these results often centers on gross margin direction and backlog trends, which offer a window into future revenue. The modest revenue increase and softer second-quarter profit reflect ongoing pressure from lower clean energy activity, especially in electrolysis applications, even as medical and electronics demand holds up. The 23% sequential backlog increase and improved cash position stand out as constructive, though attention remains on whether elevated operating expenses will continue to weigh on near-term earnings.
Management expects continued revenue growth and profitability through the first half of fiscal 2027, driven by medical-sector strength and wider use of high-ASP production-scale systems. For the full year, the company projects revenue that is relatively flat to modestly higher than fiscal 2026, noting limited visibility beyond the first half and uncertainty in parts of the clean energy market.
Several factors deserve close attention. The pace at which backlog converts to revenue matters, given that larger system orders can create quarterly lumpiness. Order momentum in medical and microelectronics remains key, as these areas have driven recent quoting activity. Cost trends also warrant monitoring since higher operating expenses drove the second-quarter profit dip. Finally, any shifts in clean energy policy that affect electrolysis demand will influence the sales mix. The stronger backlog and balance sheet provide a base, but the timing of large orders will continue to affect quarterly outcomes.
I also checked this using Tickeron’s AI Screener to see how Sono-Tek compares with peers in the industrial and clean technology space on fundamentals and recent performance trends.
When reviewing results like these, I often turn to Tickeron’s AI Screener to quickly filter peers and spot patterns in margins, backlog trends, and sector rotation. The tool helps surface relevant comparables without spending hours on manual screens, which keeps the focus on the numbers that matter most for a name like this.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day moving average for SOTK crossed bullishly above the 50-day moving average on October 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 76%.
The Momentum Indicator moved above the 0 level on September 23, 2026. You may want to consider a long position or call options on SOTK as a result. In 79 of 108 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for SOTK just turned positive on September 22, 2026. Looking at past instances where SOTK's MACD turned positive, the stock continued to rise in 36 of 50 cases over the following month. The odds of a continued upward trend are 72%.
SOTK moved above its 50-day moving average on September 30, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where SOTK advanced for three days, in 168 of 227 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The Aroon Indicator entered an Uptrend today. In 98 of 131 cases where SOTK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
SOTK broke above its upper Bollinger Band on September 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. SOTK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.890) is normal, around the industry mean (4.255). P/E Ratio (39.154) is within average values for comparable stocks, (88.653). Projected Growth (PEG Ratio) (0.390) is also within normal values, averaging (5.470). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (3.258) is also within normal values, averaging (32.028).
The Tickeron Profit vs. Risk Rating rating for this company is 62 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ElectronicEquipmentInstruments